Processes and outcomes of care for patients with community-acquired pneumonia - Results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study
Mj. Fine et al., Processes and outcomes of care for patients with community-acquired pneumonia - Results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study, ARCH IN MED, 159(9), 1999, pp. 970-980
Citations number
38
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Background: Although understanding the processes of care and medical outcom
es for patients with community-acquired pneumonia is instrumental to improv
ing the quality and cost-effectiveness of care for this illness, limited in
formation is available on how physicians manage patients with this illness
or on medical outcomes other than short-term mortality.
Objectives: To describe the processes of care and to assess a broad range o
f medical outcomes for ambulatory and hospitalized patients with community-
acquired pneumonia.
Methods: This prospective, observational study was conducted at 4 hospitals
and 1 health maintenance organization in Pittsburgh, Pa, Boston, Mass, and
Halifax, Nova Scotia. Data were collected via patient interviews and revie
ws of medical records for 944 outpatients and 1343 inpatients with clinical
and radiographic evidence of community-acquired pneumonia. Processes of ca
re and medical outcomes were assessed 30 days after presentation.
Results: Only 29.7% of outpatients had 1 or more microbiologic tests perfor
med, and only 5.7% had an assigned microbiologic cause. Although 95.7% of i
npatients had 1 or moro microbiologic tests performed, a cause was establis
hed in only 29.6%. Six outpatients (0.6%) died, and 3 of these deaths were
pneumonia related. Of surviving outpatients, 8.0% had 1 or more medical com
plications. At 30 days, 88.9% (nonemployed) to 95.6% (employed) of the surv
iving outpatients had returned to usual activities, yet 76.0% of outpatient
s had 1 or more persisting pneumonia-related symptoms. Overall, 107 inpatie
nts (8.0%) died, and 81 of these deaths were pneumonia related. Most surviv
ing inpatients (69.0%) had 1 or more medical complications. At 30 days, 57.
3% (nonemployed) to 82.0% (employed) of surviving inpatients had returned t
o usual activities, and 86.1% had 1 or more persisting pneumonia-related sy
mptoms.
Conclusions: In this study, conducted primarily at hospital sites with affi
liated medical education training programs, virtually all outpatients and m
ost inpatients had pneumonia of unknown cause. Although outpatients had an
excellent prognosis, pneumonia-related symptoms often persisted at 30 days.
Inpatients had substantial mortality, morbidity, and pneumonia-related sym
ptoms at 30 days.